L iver biopsy remains the gold standard for diagnosing and staging the nonalcoholic steatohepatitis (NASH) subtype of nonalcoholic fatty liver disease (NAFLD) in children and adults.
L iver biopsy remains the gold standard for diagnosing and staging the nonalcoholic steatohepatitis (NASH) subtype of nonalcoholic fatty liver disease (NAFLD) in children and adults. 1, 2 The perilipin (PLIN) lipid droplet proteins PLIN1 and PLIN2 have been shown previously to be up-regulated in hepatic steatosis and adult NASH, [3] [4] [5] [6] [7] however, their differential expression in pediatric NAFLD is unknown. We examined the hepatic expression of PLIN1 and PLIN2 in pediatric NAFLD and compared them with adults with NAFLD and children with steatosis caused by hepatitis C (HepC).
Methods
This study consisted of archived samples and was reviewed and granted exempt status by the Institutional Review Board at Indiana University. Twenty-five pediatric and 29 adult paraffin-embedded liver sections were immunostained with PLIN1 and PLIN2 antibodies. Liver histology was analyzed independently for steatosis and inflammation and categorized as normal, nonalcoholic fatty liver (NAFL), NASH, or HepC. PLIN1 and PLIN2 immunostaining was scored on a qualitative scale of 0 to 5 by a reviewer blinded to patient diagnosis: 0 represented no staining, 1 represented less than 5% staining, 2 represented 5% to 10% staining, 3 represented 11% to 49% staining, 4 represented 50% to 75% staining, and 5 represented more than 75% staining.
Statistical Analysis
Data were analyzed by analysis of variance and the Neuman-Keuls test. A P value less than .05 was considered significant.
Results

Clinical Characteristics
Among children, 5 had normal histology, 6 had NAFL, 9 had NASH, and 5 had HepC. The adults included 15 with normal livers, 3 with NAFL, and 11 with NASH. Pediatric controls were younger than those with steatotic diseases (7 vs 13; P < .0005); however, there was no difference in age among pediatric NAFL, NASH, and HepC patients. Body mass index (BMI) in pediatric NAFL and NASH patients was twice that of controls (36 vs 17 mg/ kg; P < .0001). Patients with HepC had an average BMI of 20.7 mg/kg, which was intermediate between control and the NAFLD cohorts. The mean age of the adult control and NAFL patients was 49 years, and was 43 years in NASH patients (P ¼ .56). The average BMI among adult NAFL patients was 25 kg/m 2 compared with 35 kg/m 2 for NASH patients (P ¼ .009). There was no difference in serum transaminase levels among the pediatric or adult groups.
Hepatic Perilipin Immunostaining in Children and Adults
In pediatric controls, PLIN1 immunostaining was absent. PLIN1 was present in 1 child with HepC, mildly expressed in NAFL (0.83 AE 0.4), and increased in NASH (1.67 AE 0.5; P < .05 vs control). Unlike PLIN1, low levels of PLIN2 were detected in the livers of control children (0.6 AE 0.24). Compared with control, PLIN2 staining was more pronounced in NAFL (1.8 AE 0.4; P .01), NASH (2.3 AE 0.2; P .001), and HepC (2.4 AE 0.24; P .01) (Figure 1) .
In adults, PLIN1 immunostaining was detected in only 1 control adult and was significantly higher in adult NASH compared with NAFL (2.4 AE 0.04 vs 1.5 AE 0.28; P .01). PLIN2 was detected at low levels in controls (0.5 AE 0.13) and was increased significantly in both NAFL (4.75 AE 0.25) and NASH (4.27 AE 0.23) (P < .0001 vs control) (Figure 1 ).
These data suggest that similar to adult patients, PLIN1 is expressed de novo in pediatric NAFLD and increased significantly in NASH. In addition, there is differential expression of PLIN1 in pediatric NASH compared with HepC.
Discussion
NAFLD is one of the few hepatic diseases that impacts both children and adults at alarmingly high rates. Epidemiologic studies have shown that there is a divergence in risk of disease progression and mortality in patients with NAFL and NASH. 1, 8 However, pathologic distinction between these clinical subtypes is challenging.
We describe the use of perilipin proteins in the histopathologic distinction of pediatric NAFL and NASH. Here, we show that similar to adults, PLIN2 is an abundant hepatic LD protein that is present in both normal and disease states in children and is therefore a nonspecific histologic marker of hepatic steatosis. In contrast, PLIN1 is not detectable in the majority of normal livers, is increased modestly in NAFL, and has the highest expression in hepatic steatosis resulting from NASH compared with control, NAFL, and hepatitis C virus. These data suggest that the combination of PLIN1 and PLIN2 immunostaining may be a useful histologic tool in NAFLD children. Further studies are needed to confirm if this relationship is maintained in a larger cohort of pediatric and adult NAFLD patients. # P < .05, *P .01, **P .001, and ***P .0001.
